CERUS CORP(CERS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,188 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in CERS
Events flagged as statistical outliers against CERS's own multi-year baseline — not fixed dollar thresholds.
CERS Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for CERUS CORP (CERS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CERS at 38.5/100 on a 32-signal composite quality model, placing it at rank #2,188 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (18.0) and revenue scale (24.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 16.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), CERUS CORP reports quarterly revenue of $57.4M, net income of $-2.9M, an operating margin of -3.2%. Top institutional holders of CERS by reported 13-F value include BlackRock, ARK Investment Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CERS trades on the Nasdaq exchange and files with the SEC under CIK 1020214. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CERS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CERUS CORP directly from SEC EDGAR. CERUS CORP's 13F Pro composite quality score has ranged between 15 and 45 since 2021, currently 38.5 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$57.4M
Net Income
Q2 2026
$-2.9M
Free Cash Flow
Q2 2026
$-3.5M
Operating Margin
Q2 2026
-3.2%
ROIC
Q2 2026
-10.6%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+16.1% YoYNet Income
+25.3% YoYOperating Income
+39.0% YoYEPS (Diluted)
+27.3% YoYTotal Assets
+10.4% YoYOp. Cash Flow
-57.4% YoYFree Cash Flow
-87.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $233.8M +16.1% | $201.3M +7.8% | $186.8M -0.8% | $188.3M +18.1% | $159.5M +39.6% | $114.2M |
| Net Income | $-15.6M +25.3% | $-20.9M +44.2% | $-37.5M +12.4% | $-42.8M +21.3% | $-54.4M +9.2% | $-59.9M |
| Operating Income | $-8.7M +39.0% | $-14.2M +52.7% | $-30.1M +11.8% | $-34.1M +30.4% | $-48.9M +16.1% | $-58.3M |
| EPS (Diluted) | $-0.08 +27.3% | $-0.11 +47.6% | $-0.21 +12.5% | $-0.24 +25.0% | $-0.32 +13.5% | $-0.37 |
| Total Assets | $221.9M +10.4% | $200.9M +1.6% | $197.7M -9.3% | $218.1M -8.2% | $237.5M +7.3% | $221.4M |
| Operating Cash Flow | $4.8M -57.4% | $11.4M +126.3% | $-43.2M -68.5% | $-25.6M +24.5% | $-33.9M +18.9% | $-41.8M |
| Free Cash Flow | $1.1M -87.0% | $8.5M +117.8% | $-47.8M -73.0% | $-27.6M +20.7% | $-34.8M +19.8% | $-43.4M |
Get alerted when CERS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CERUS CORP including:
Top Institutional Holders of CERS
BlackRock, Inc.
$64.9M22,215,127 shARK Investment Management LLC
$52.4M17,932,099 shVANGUARD CAPITAL MANAGEMENT LLC
$25.0M8,563,424 shBAKER BROS. ADVISORS LP
$18.7M6,395,431 shD. E. Shaw & Co., Inc.
$16.0M5,485,983 shGEODE CAPITAL MANAGEMENT, LLC
$15.0M5,119,019 shSTATE STREET CORP
$13.9M4,753,962 shSenvest Management, LLC
$13.5M4,614,061 shACADIAN ASSET MANAGEMENT LLC
$12.5M4,270,074 shSumitomo Mitsui Trust Holdings, Inc.
$12.1M4,139,532 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $64.9M | 22,215,127 |
| ARK Investment Management LLC | $52.4M | 17,932,099 |
| VANGUARD CAPITAL MANAGEMENT LLC | $25.0M | 8,563,424 |
| BAKER BROS. ADVISORS LP | $18.7M | 6,395,431 |
| D. E. Shaw & Co., Inc. | $16.0M | 5,485,983 |
| GEODE CAPITAL MANAGEMENT, LLC | $15.0M | 5,119,019 |
| STATE STREET CORP | $13.9M | 4,753,962 |
| Senvest Management, LLC | $13.5M | 4,614,061 |
| ACADIAN ASSET MANAGEMENT LLC | $12.5M | 4,270,074 |
| Sumitomo Mitsui Trust Holdings, Inc. | $12.1M | 4,139,532 |
Companies Similar to CERS
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
NeuroPace Inc
GeneDx Holdings Corp.
Schrodinger, Inc.
ORTHOPEDIATRICS CORP
Fulgent Genetics, Inc.
MANNKIND CORP
Beta Bionics, Inc.
Twist Bioscience Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put CERS on your watchlist
Track score changes the day CERUS CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CERS a good stock to buy?
13F Pro's AI-powered analysis of CERUS CORP (CERS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CERS are available on the CERS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CERS is classified as a small company.
Which hedge funds own CERS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CERS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CERUS CORP's investment landscape.